Carregant...
Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
BACKGROUND: Determination of β-amyloid (Aβ) positivity and likelihood of underlying Alzheimer’s disease (AD) relies on dichotomous biomarker cut-off values. Individuals with mild cognitive impairment (MCI) and Aβ within the normal range may still have a substantial risk of developing dementia, prima...
Guardat en:
| Publicat a: | Alzheimers Res Ther |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6896336/ https://ncbi.nlm.nih.gov/pubmed/31805990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0557-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|